# FDA recall D-0189-2024

> **CARDINAL HEALTHCARE** · Class II · drug recall initiated 2022-01-26.

## Product

Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505.  NDC: 0378-1300-01

## Reason for recall

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

## Distribution

Nationwide USA

## Key facts

- **Recall number:** D-0189-2024
- **Recalling firm:** CARDINAL HEALTHCARE
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-01-26
- **Report date:** 2024-01-03
- **Termination date:** 2024-09-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dublin, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0189-2024

## Citation

> AI Analytics. FDA recall D-0189-2024. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0189-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*